6505--Esomeprazole Capsules (VA-27-00001026)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA) National Acquisition Center intends to issue an unrestricted Request for Proposal (RFP) #36E79726R0027 for Esomeprazole Magnesium Capsules. This procurement aims to secure an uninterrupted source of supply for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The solicitation is expected to be issued around June 9, 2026, with a tentative closing date for proposals of June 23, 2026.
Scope of Work
This opportunity is for the supply of Esomeprazole Magnesium Capsules in both 20mg and 40mg strengths. Key requirements include:
- Product: Esomeprazole 20mg EC Capsules and Esomeprazole 40mg EC Capsules.
- Packaging: Specific unit-of-use packaging in 30-count and 90-count bottles. Options for 500-count or 1000-count bottles are also specified for certain line items.
- Bottle Specifications: All unit-of-use packaging must feature a safety-cap (deshellable and/or convertible to a non-safety cap) and a bottle with a minimum 120cc volume, a cylindrical body, and a minimum 5.75-inch circumference. The safety cap must not exceed the bottle's diameter.
- Labeling: Bottles must accommodate a 5.25-inch x 2-inch label, with an additional 0.5-inch space required for barcode exposure and/or display of expiration date and lot number.
- Offeror Requirements: Offerors must provide the exact drug name as it appears on the label and possess a unique National Drug Code (NDC) number for the product. The successful offeror's label with its unique NDC shall be the only label on the product, with VA labels designed to securely adhere over it.
Contract Details
- Contract Type: Unrestricted procurement.
- Award: One contract will be awarded to a responsible offeror capable of providing an uninterrupted supply.
- Period of Performance: One base year plus four pre-priced one-year option periods.
- Distribution: Contracted items will be distributed through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs.
- NAICS Code: 325412 (Drugs And Biologicals).
Submission & Evaluation
- Solicitation Release: RFP #36E79726R0027 will be issued electronically in commercial item format (FAR Part 12) around June 9, 2026.
- Proposal Due Date: Tentative closing date for proposals is June 23, 2026.
- Submission Method: Electronic only; no paper copies or telephone requests will be accepted.
- Monitoring: Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for amendments and updates. All responsible sources may submit a timely offer.
Estimated Annual Requirements
The estimated annual usage includes:
- Esomeprazole 20mg EC Cap: 30-count (55,112 bottles), 90-count (21,059 bottles), 500-count (3,884 bottles) OR 1000-count (1,942 bottles).
- Esomeprazole 40mg EC Cap: 30-count (299,341 bottles), 90-count (22,995 bottles), 500-count (11,208 bottles) OR 1000-count (5,604 bottles).
Point of Contact
For questions, contact James Sullivan, Contract Specialist, at james.sullivan3@va.gov.